News
8h
ABP News on MSNBeyond The Hype — What India Must Know About Weight-Loss DrugsWeight-loss injections like semaglutide are trending in India, but are they safe? Know the science, risks, and why expert ...
Miracle’ drugs used for weight-loss like Semaglutide and Tirzepatide—better known by their brand names Ozempic and ...
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
4h
News-Medical.Net on MSNWhich GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answersResearchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
Pharmacists warn that the escalating demand for weight loss drugs may soon exceed supply, potentially driving consumers to ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Explore more
1h
Vietnam Investment Review on MSNAscletis Begins Dosing in U S Phase IIa Study for Monthly GLP 1R Obesity DrugAscletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the first participants with obesity or overweight with at least one weight-related comorbidity have been dosed in its U.S. 12-week ...
5h
ABP News on MSNCan You Regain Weight After You Stop Taking Drugs Like Ozempic?A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...
Eli Lilly and Company (NYSE:LLY) is experiencing a strong analyst sentiment amid its expanding role in cutting-edge ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results